We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

109 hedge funds and large institutions have $812M invested in Epizyme, Inc in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 29

2% more call options, than puts

Call options by funds: $754K | Put options by funds: $739K

0% more funds holding

Funds holding: 109 → 109 (0)

0% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 18

24% less capital invested

Capital invested by funds: $1.06B → $812M (-$252M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
109
Holders Change
–
Holders Change %
0%
% of All Funds
2.5%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
18
Increased
48
Reduced
29
Closed
18
Calls
$754K
Puts
$739K
Net Calls
+$15K
Net Calls Change
-$212K

Top Buyers

Rank Fund Capital Flow
1
Primecap Management
Primecap Management
California
+$21.6M
2
DM
Deerfield Management
New York
+$10.6M
3
VOYA Investment Management
VOYA Investment Management
Georgia
+$8.97M
4
Morgan Stanley
Morgan Stanley
New York
+$6.49M
5
BlackRock
BlackRock
New York
+$6.33M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$20.7M
2
Franklin Resources
Franklin Resources
California
-$17M
3
Millennium Management
Millennium Management
New York
-$12.2M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.78M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$8.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$3.06M +$93.6K +6,012 +3%
Point72 Asset Management
27
Point72 Asset Management
Connecticut
$2.52M -$8.78M -564,000 -75%
UONDDL
28
University of Notre Dame du Lac
Indiana
$2.36M +$553K +35,551 +26%
TCIM
29
TIAA CREF Investment Management
New York
$2.25M +$860K +55,265 +50%
PP
30
PDT Partners
New York
$2.12M -$5.34K -343 -0.2%
MWNA
31
Marshall Wace North America
New York
$1.87M +$2.15M +138,239 New
JP Morgan Chase
32
JP Morgan Chase
New York
$1.79M -$980K -62,962 -32%
OIM
33
Oracle Investment Management
Connecticut
$1.72M -$4.19M -269,182 -68%
Deutsche Bank
34
Deutsche Bank
Germany
$1.7M +$33.7K +2,166 +2%
Goldman Sachs
35
Goldman Sachs
New York
$1.54M -$128K -8,249 -7%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$1.53M -$350K -22,500 -17%
AA
37
ALPS Advisors
Colorado
$1.37M +$123K +7,918 +9%
TA
38
Teachers Advisors
New York
$1.33M +$163K +10,499 +12%
Swiss National Bank
39
Swiss National Bank
Switzerland
$1.23M +$104K +6,700 +8%
UBS Group
40
UBS Group
Switzerland
$1.15M -$471K -30,237 -26%
QI
41
QS Investors
New York
$1.12M – – –
Federated Hermes
42
Federated Hermes
Pennsylvania
$1.09M +$858K +55,135 +219%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$1.08M +$87.3K +5,608 +8%
AllianceBernstein
44
AllianceBernstein
Tennessee
$1.06M +$374K +24,000 +44%
Hudson Bay Capital Management
45
Hudson Bay Capital Management
Connecticut
$1.02M +$234K +15,046 +25%
DekaBank Deutsche Girozentrale
46
DekaBank Deutsche Girozentrale
Germany
$982K +$233K +15,000 +25%
Jacobs Levy Equity Management
47
Jacobs Levy Equity Management
New Jersey
$970K +$394K +25,300 +55%
Millennium Management
48
Millennium Management
New York
$948K -$12.2M -781,529 -92%
CS
49
Credit Suisse
Switzerland
$914K -$208K -13,376 -17%
ARTA
50
A.R.T. Advisors
New York
$906K +$310K +19,895 +42%
1
2
3 4 5

EPZM Hedge Fund Activity: Q2 2018 in Review

109 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q2 2018, worth a combined $812M — down 24% from $1.06B a quarter earlier.

Fund positioning in EPZM was balanced in Q2 2018: 18 funds opened new positions, 18 closed out, 48 added to existing stakes and 29 trimmed.

The largest buyer was Primecap Management, adding an estimated $21.6M. The largest seller was Fidelity Investments, cutting an estimated $20.7M.

  • 109 institutional investors held Epizyme, Inc (EPZM) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $812M of Epizyme, Inc stock for Q2 2018, down 24% quarter-over-quarter.
  • 18 funds opened new Epizyme, Inc positions in Q2 2018 and 18 closed out, a net change of 0 holders.
  • The largest Epizyme, Inc buyer in Q2 2018 was Primecap Management, an estimated $21.6M added.
  • The largest Epizyme, Inc seller in Q2 2018 was Fidelity Investments, an estimated $20.7M sold.

Based on aggregated 13F filings for Q2 2018.